Zacks Investment Research
10 Feb 2026, 15:35 UTC · 31w ago
Verdict
Headline leans bearish. We score INGN +0.60 across four claims.
Score contradicts the headline.
Leans bearish
From its wording — no explicit rating
+0.60strongly bullish
What the story claims
4 claims · scored −1 bearish … +1 bullish
The consensus EPS estimate for Inogen (INGN) has increased by 8.9% over the last 30 days.
More positive than 92% of claims this week
Inogen currently holds a Zacks Rank #2 (Buy), placing it in the top 20% of stocks based on earnings estimate revisions and EPS surprises.
Continue reading
5 related stories
More positive than 71% of ticker scores this week
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 85% of claims this week
Inogen's Relative Strength Index (RSI) is 29.69, indicating the stock is in oversold territory.
More positive than 63% of claims this week
Inogen's stock price has declined 10% over the past four weeks.
More negative than 69% of claims this week
Which stocks this story touches
More positive than 71% of ticker scores this week
The company has a Zacks Rank #2 (Buy), is in oversold territory, and has seen a rise in consensus EPS estimates.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
3d ago
−8.1%
Price is moving against the score
$5.14 vs $5.59 close before publication (Feb 9) · not market-adjusted
INGN chart →
